Mirae Asset Global ETFs Holdings
VNDA icon

Mirae Asset Global ETFs Holdings’s Vanda Pharmaceuticals VNDA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$197K Sell
32,091
-413
-1% -$2.7K ﹤0.01% 2486
2026
Q1 		$223K Buy
32,504
+6,672
+26% +$51.5K ﹤0.01% 2305
2025
Q4 		$228K Sell
25,832
-306
-1% -$1.68K ﹤0.01% 2293
2025
Q3 		$130K Sell
26,138
-4,357
-14% -$20.2K ﹤0.01% 2547
2025
Q2 		$144K Sell
30,495
-3,570
-10% -$15.6K ﹤0.01% 2435
2025
Q1 		$156K Buy
34,065
+1,488
+5% +$6.94K ﹤0.01% 2435
2024
Q4 		$156K Buy
32,577
+1,395
+4% +$6.7K ﹤0.01% 2512
2024
Q3 		$146K Buy
31,182
+1,896
+6% +$10.2K ﹤0.01% 2529
2024
Q2 		$165K Buy
+29,286
New +$151K ﹤0.01% 2351

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's VNDA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Vanda Pharmaceuticals (VNDA) stake by 1.3% in Q2 2026, selling an estimated $2.7K and leaving 32,091 shares worth $197K. The position accounts for ﹤0.01% of the portfolio, ranked #2486.

Mirae Asset Global ETFs Holdings first reported a position in VNDA in Q2 2024 and has held it in 9 quarters since. The position peaked at $228K in Q4 2025. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 32,091 shares of Vanda Pharmaceuticals worth $197K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 413 Vanda Pharmaceuticals shares in Q2 2026, an estimated $2.7K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2486 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Vanda Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Vanda Pharmaceuticals position peaked at $228K in Q4 2025.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.